CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
The NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) invites you to view its monthly lecture series.
With the goal of informing the National Cancer Institute (NCI) community about the variety of ongoing research in cancer and complementary and alternative medicine (CAM), NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) has created a monthly lecture series on cancer CAM. These hour long lectures, occurring from 10 a.m. - 11 a.m. on the second Wednesday of each month, will feature a fifty minute presentation on a cancer CAM topic and allow ten minutes for questions.
Curcumin/TRAIL combination therapy for prostate cancer [electronic resource] / Subhash Gautam.
Series:
NCI OCCAM monthly lecture series
Author:
Gautam, Subhash. National Cancer Institute (U.S.). Office of Cancer Complementary and Alternative Medicine.
Publisher:
[Bethesda, Md. : National Institutes of Health, 2009]
Other Title(s):
NCI OCCAM monthly lecture series
Abstract:
(CIT): The NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) invites you to view its monthly lecture series. With the goal of informing the National Cancer Institute (NCI) community about the variety of ongoing research in cancer and complementary and alternative medicine (CAM), NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) has created a monthly lecture series on cancer CAM. These hour long lectures, occurring from 10 a.m. - 11 a.m. on the second Wednesday of each month, will feature a fifty minute presentation on a cancer CAM topic and allow ten minutes for questions. For more information, visit http://www.cancer.gov/cam/news/monthly-lecture-series.html.
Subjects:
Curcumin--therapeutic use Prostatic Neoplasms--drug therapy TNF-Related Apoptosis-Inducing Ligand--therapeutic use
